Holen Sie sich die Stockscreener-App
56.30
3.32%
1.81
Finanzdaten der Apogee Therapeutics Inc-Aktie (APGE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-09-30 |
| Periodenlänge | 3 Monate | 3 Monate |
| Revenues |
-
|
- |
Operating Expenses
|
57.09%
38.18
|
24.30 |
| Operating Income/Loss |
57.09%
-38.18
|
-24.30 |
| Income/Loss From Continuing Operations Before Tax |
54.00%
-32.09
|
-20.84 |
| Income/Loss From Continuing Operations After Tax |
54.00%
-32.09
|
-20.84 |
|
Net Income/Loss
|
54.00%
-32.09
|
-20.84 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- |
| Attributable To Noncontrolling Interest |
-
|
- |
| Basic Average Shares |
21.73%
50.19
|
41.23 |
| Diluted Average Shares |
21.73%
50.19
|
41.23 |
| Basic Earnings Per Share |
25.49%
-0.64
|
-0.51 |
| Diluted Earnings Per Share |
25.49%
-0.64
|
-0.51 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- |
5.11%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):